Sheila M. Dowd

Rush University Medical Center — United States

Neuroscience · Life Sciences

16h-index1.1kcitations55works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Transcranial Magnetic Stimulation Studies(13), Electroconvulsive Therapy Studies(11), Treatment of Major Depression(10), Schizophrenia research and treatment(9), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes(7)

Publications55 total

Psychologists’ Well-Being, Stressors, and Practices in Academic Health Centers: A Peri-Pandemic Update
Journal of Clinical Psychology in Medical Settings·2025· 1 cited
Exploring study dropout in drug trials for adults with PTSD: insights from a conventional and individual participant data meta-analysis
European journal of psychotraumatology·2025Open Access
The influence of neuropeptide Y (NPY) on the relationship between emotion regulation and mood-related pathology in survivors of childhood interpersonal trauma
Journal of Affective Disorders·2024Open Access
What good are positive emotions for treatment? A replication test of whether trait positive emotionality predicts response to exposure therapy for social anxiety disorder
Behaviour Research and Therapy·2023· 14 citedOpen Access
Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT
Journal of Psychiatric Research·2023· 4 citedOpen Access
The Eyes Have It: Psychotherapy in the Era of Masks
Journal of Clinical Psychology in Medical Settings·2022· 34 citedOpen Access
Sleep quality and outcome of exposure therapy in adults with social anxiety disorder
Depression and Anxiety·2021· 17 citedOpen Access
COVID-19 innovations: The center for clinical wellness at Rush University Medical Center
PsycEXTRA Dataset·2021
Dose Timing of <scp>D</scp>-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder
JAMA Network Open·2020· 32 citedOpen Access
Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone <i>vs</i> placebo for the treatment of patients with post-traumatic stress disorder and insomnia
World Journal of Psychiatry·2020· 19 citedOpen Access
Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder
PLoS ONE·2019· 23 citedOpen Access
0339 Effectiveness of Recruiting Type 1 Narcolepsy Patients via Internet Based Pre-selection System
SLEEP·2018Open Access
Narcolepsy: validation of a daily electronic diary
Sleep Medicine·2017
Effectiveness of recruiting type 1 narcolepsy patients via internet based pre-selection system
Sleep Medicine·2017
Depression and Anxiety Issue Information
Depression and Anxiety·2016Open Access
RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER
Depression and Anxiety·2016· 68 citedOpen Access
Erratum to “Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study” [Brain Stimulation 9 (2016) 251–257]
Brain stimulation·2016Open Access
d-cycloserine augmentation of exposure therapy: Review and new directions
Data Archiving and Networked Services (DANS)·2016· 3 citedOpen Access
Major Depressive Disorder in a Nutshell
PsycCRITIQUES·2016
Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study
Brain stimulation·2015· 77 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Philip G. Janicak(23), Mark H. Pollack(13), Michael W. Otto(9), Stefan G. Hofmann(9), Rajiv P. Sharma(8), Jasper A. J. Smits(7), David Rosenfield(6), Mark A. Demitrack(5), Alyson K. Zalta(5), Christina D. Dutcher(5), Jeffrey Rado(5), Mary Jane Strong(4), Noah S. Philip(4), David L. Dünner(4), David G. Brock(4), Mark S. George(4), John M. Davis(4), Danesh Alam(3), Shirlene Sampson(3), Linda L. Carpenter(3)